DK0975761T3 - Humant, rekombinant beta-interferon med forbedret opløselighed - Google Patents

Humant, rekombinant beta-interferon med forbedret opløselighed

Info

Publication number
DK0975761T3
DK0975761T3 DK98920533T DK98920533T DK0975761T3 DK 0975761 T3 DK0975761 T3 DK 0975761T3 DK 98920533 T DK98920533 T DK 98920533T DK 98920533 T DK98920533 T DK 98920533T DK 0975761 T3 DK0975761 T3 DK 0975761T3
Authority
DK
Denmark
Prior art keywords
phe
leu
interferon
human
improved solubility
Prior art date
Application number
DK98920533T
Other languages
English (en)
Inventor
Christian Schneider-Fresenius
Bernd Otto
Gero Waschuetza
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of DK0975761T3 publication Critical patent/DK0975761T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK98920533T 1997-04-23 1998-04-16 Humant, rekombinant beta-interferon med forbedret opløselighed DK0975761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19717864A DE19717864C2 (de) 1997-04-23 1997-04-23 Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
PCT/EP1998/002238 WO1998048018A1 (de) 1997-04-23 1998-04-16 HUMANES, REKOMBINANTES INTERFERON-β MIT VERBESSERTER LÖSLICHKEIT

Publications (1)

Publication Number Publication Date
DK0975761T3 true DK0975761T3 (da) 2004-02-16

Family

ID=7827959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98920533T DK0975761T3 (da) 1997-04-23 1998-04-16 Humant, rekombinant beta-interferon med forbedret opløselighed

Country Status (10)

Country Link
US (3) US6572853B1 (da)
EP (1) EP0975761B1 (da)
JP (1) JP4189035B2 (da)
AT (1) ATE257859T1 (da)
CA (1) CA2287521C (da)
DE (2) DE19717864C2 (da)
DK (1) DK0975761T3 (da)
ES (1) ES2214709T3 (da)
PT (1) PT975761E (da)
WO (1) WO1998048018A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
EP1012184B1 (en) * 1997-07-14 2007-10-10 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
ATE432288T1 (de) 2001-02-27 2009-06-15 Maxygen Aps Neue interferon-beta-ähnliche moleküle
AU2003254641A1 (en) * 2002-08-28 2004-03-19 Maxygen Aps Interferon beta-like molecules for treatment of cancer
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
AU2003277088A1 (en) * 2002-10-01 2004-04-23 Xencor, Inc Interferon variants with improved properties
WO2005003157A2 (en) * 2003-06-10 2005-01-13 Xencor, Inc. Interferon variants with improved properties
GB2429207A (en) 2004-02-02 2007-02-21 Ambrx Inc Modified human interferon polypeptides and their uses
KR100781666B1 (ko) 2004-11-02 2007-12-03 신영기 인간 인터페론-베타 변이체
US20080038224A1 (en) * 2006-03-28 2008-02-14 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
JP5313129B2 (ja) * 2006-05-02 2013-10-09 アロザイン， インコーポレイテッド 非天然アミノ酸置換ポリペプチド
CN103965347B (zh) 2007-05-02 2017-07-18 Ambrx公司 经修饰干扰素β多肽和其用途
EP3103880A1 (en) 2008-02-08 2016-12-14 Ambrx, Inc. Modified leptin polypeptides and their uses
DE102008051574A1 (de) 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
EP2431051A1 (en) * 2010-09-15 2012-03-21 Vakzine Projekt Management GmbH Type-1 interferons for the treatment of multiple sclerosis
IN2014CN02982A (da) 2011-10-01 2015-07-03 Glytech Inc
BR112015024423B1 (pt) 2013-03-29 2023-04-25 Glytech, Inc Polipeptídeo glicosilado tendo atividade de interferon ?, composição farmacêutica e uso de um polipeptídeo glicosilado

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
GB8412564D0 (en) 1984-05-17 1984-06-20 Searle & Co Structure and properties
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
DE59810596D1 (de) 2004-02-19
JP4189035B2 (ja) 2008-12-03
WO1998048018A1 (de) 1998-10-29
EP0975761A1 (de) 2000-02-02
US6572853B1 (en) 2003-06-03
DE19717864C2 (de) 2001-05-17
ES2214709T3 (es) 2004-09-16
JP2001523957A (ja) 2001-11-27
US20040022763A1 (en) 2004-02-05
EP0975761B1 (de) 2004-01-14
DE19717864A1 (de) 1998-10-29
US20060093579A1 (en) 2006-05-04
CA2287521C (en) 2009-08-11
US7575894B2 (en) 2009-08-18
CA2287521A1 (en) 1998-10-29
PT975761E (pt) 2004-05-31
ATE257859T1 (de) 2004-01-15
US7052687B2 (en) 2006-05-30

Similar Documents

Publication Publication Date Title
DK0975761T3 (da) Humant, rekombinant beta-interferon med forbedret opløselighed
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
ES2141229T3 (es) Productos farmaceuticos de proteinas y peptidos modificados.
HU9200548D0 (en) Improved activity process of recombined proteins
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
ATE194917T1 (de) Flüssige beta-interferon formulierungen
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
ATE105841T1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
EP0296227A4 (en) ADMINISTRATION OF AMINOACIDS BY NASAL ROUTE.
AR243865A1 (es) Procedimientos para fabricar derivados de aminoacidos; y silil derivados de aminoacidos utiles como intermediarios en dicho procedimiento.
AU1454495A (en) Recombinant production of modified proteins lacking certain amino acids
AU4426689A (en) Recombinant polypeptides of the hemorragic septicemy virus of fish
IT8748754A0 (it) Procedimento per la produzione di pool di aminoacidi mediante idrolisi enzimatica di substrati proteici naturali